Mercado-Díaz MÁ, Urencio-Marcué M, Ramírez-Del Val F, Domínguez-Rosado I

Language: Spanish
References: 20
Page: 145-150
PDF size: 188.29 Kb.

ABSTRACT

Background: The estimated prevalence of nonalcoholic fatty liver disease (NAFLD) in the overall population is 30%. Bile duct injuries associated with cholecystectomy have a constant frequency and some patients with these types of lesions have concomitant liver steatosis. It has not been determined if liver steatosis has a negative outcome on the results of surgical bile duct repair.
Methods: Among a cohort of patients surgically repaired for bile duct injury, we selected those from whom a liver biopsy was obtained. Patients were divided into the following groups: group I-liver steatosis, group II-no steatosis. The groups were compared for long-term results of the reconstruction, posoperative complications, liver function test and need for reintervention.
Results: From group I we obtained 18 patients and from group II 71 patients. In 11% of the steatosis group and in 10% of the nonsteatosis group anastomosis dysfunction was observed. Three cases in group I (17%) and 11 patients in group II (15.5%) needed further surgical reintervention. Complete rehabilitation was obtained in 77% of the cases in group I and 66% of patients in group II. No statistical differences were found in any features between groups.
Conclusions: Patients with liver steatosis have a higher incidence of gallstone disease than the general population; hence, an increased probability of having a bile duct injury. The results of surgical reconstruction after these lesions are similar to those of patients without steatosis. Analyzed data showed no repercussion in outcome of patients with liver steatosis.

REFERENCES

1. Cornier MA, Dabelea D, Hernández TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008;29:777-822.

2. Jiang J, Torok N. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Synd Rel Dis 2008;6:1-7.

3. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-S112.

4. Luyckx FH, Desaive C, Thiry A, Dewé W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-226.

5. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219.

6. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 2005;22:1129-1133.

7. Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, Pérez- Morales AG, Martínez S, Cid-Juárez S. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 2008;12: 2097-2102 (discussion 2102).

8. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005;20:1176-1184.

9. Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicolog Sci 2007;32:453-468.

10. Chapman WC, Abecassis M, Jarnagin W, Mulvihill S, Strasberg SM. Bile duct injuries 12 years after the introduction of laparoscopic cholecystectomy. J Gastrointest Surg 2003;7:412-416.

11. Flum DR, Cheadle A, Prela C, Dellinger EP, Chan L. Bile duct injury during cholecystectomy and survival in Medicare beneficiaries. JAMA 2003;290:2168-2173.

12. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, Mc- Cullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.

13. McDonald ML, Farnell MB, Nagorney DM, Ilstrup DM, Kutch JM. Benign biliary strictures: repair and outcome with a contemporary approach. Surgery 1995;118:582-590 (discussion 90-91).

14. Strasberg SM. Clinical practice. Acute acalculous cholecystitis. N Engl J M 2008;358:2804-2811.

15. Mathur A, Pitt HA, Marine M, Mathur A, Saxena R, Schmidt CM, et al. Fatty pancreas: a factor in posoperative pancreatic fistula. Ann Surg 2007;246:1058-1064.

16. Cairns SR, Peters TJ. Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects. Clin Sci 1983;65:645-652.

17. Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol 2008;103:1036-1042.

18. Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 2005;10:3093-3099.

19. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007;27:173-193.

20. Strasberg SM, Picus DD, Drebin JA. Results of a new strategy for reconstruction of biliary injuries having an isolated right-sided component. J Gastrointest Surg 2001;5:266-274.